Early research (Phase 1)Study completedNCT01574937What this trial is testingXL-184+Abiraterone in Post-Chemo CRPCWho this might be right forProstate Cancer Dana-Farber Cancer Institute 27
Early research (Phase 1)Study completedNCT02625857What this trial is testingSafety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate CancerWho this might be right forProstatic Neoplasms, Castration-Resistant Janssen Research & Development, LLC 26
Early research (Phase 1)Looking for participantsNCT07493512What this trial is testingTrial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC) Amgen 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04419402What this trial is testingEnzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Australian and New Zealand Urogenital and Prostate Cancer Trials Group 162
Not applicableLooking for participantsNCT04146077What this trial is testingActive Surveillance for Low Risk Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma I.M. Sechenov First Moscow State Medical University 100
Large-scale testing (Phase 3)Study completedNCT00598312What this trial is testingSafety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate CancerWho this might be right forProstate Cancer Oakwood Laboratories, LLC 201
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757What this trial is testingInvestigate APL-5125 in Adults With Advanced Solid TumorsWho this might be right forColorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more Apollo Therapeutics Ltd 100
Large-scale testing (Phase 3)Looking for participantsNCT06320067What this trial is testingA Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate CancerWho this might be right forProstate Cancer Metastatic University College, London 3,360
Testing effectiveness (Phase 2)Ended earlyNCT00521781What this trial is testingStudy of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerWho this might be right forProstatic Neoplasms The Methodist Hospital Research Institute 14
Testing effectiveness (Phase 2)Study completedNCT00006019What this trial is testingPhenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerWho this might be right forLeukemiaLung CancerLymphoma+3 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06044857What this trial is testingPSMA PET Response Guided SabR in High Risk PcaWho this might be right forProstate Adenocarcinoma University of Texas Southwestern Medical Center 20
Not applicableNot Yet RecruitingNCT07112612What this trial is testingMinimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate CancerWho this might be right forMRDProstate CancermHSPC Anhui Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00039624What this trial is testingMagnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT07288359What this trial is testingStudy of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsWho this might be right forAdvanced HR+/HER2- Breast CancerAdvanced CCNE1-amplified Solid TumorsMetastatic Castration-resistant Prostate Cancer Novartis Pharmaceuticals 205
Not applicableUnknownNCT02651896What this trial is testingHypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate CancerWho this might be right forProstatic Neoplasms Hospital Sirio-Libanes 130
Not applicableStudy completedNCT01120262What this trial is testingS9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and GoserelinWho this might be right forProstate Cancer SWOG Cancer Research Network 545
Not applicableUnknownNCT06497283What this trial is testingBinaural Sound for Remimazolam MaintenanceWho this might be right forGeneral AnesthesiaProstate Cancer StageUterine Myoma Gangnam Severance Hospital 72
Not applicableLooking for participantsNCT06178354What this trial is testingFocal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate CancerWho this might be right forLocalized Prostate CarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more University of California, Davis 100
Testing effectiveness (Phase 2)Ended earlyNCT04928820What this trial is testing68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyWho this might be right forBiochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more Jonsson Comprehensive Cancer Center 22